| 标题 |
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Neurology 作者:John W Day; Richard S. Finkel; Claudia A. Chiriboga; Anne M. Connolly; Thomas O. Crawford; et al 出版日期:2021-03-18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)